Identification of novel biomarkers of response to ATR inhibitors in ARID1A mutant ovarian clear cell carcinoma

被引：1
|
作者：
Stewart, J. R. [1 ]
Baxter, J. [1 ]
Zatreanu, D. [1 ]
Brough, R. [1 ]
Song, F. [1 ]
Konde, A. [1 ]
Krastev, D. [1 ]
Alexander, J. [2 ]
Natrajan, R. [2 ]
Pettitt, S. [1 ]
Banerjee, S. [3 ]
Lord, C. [1 ]
机构：
[1] ICR Inst Canc Res, Chester Beatty Labs, Gene Funct & Breast Canc Res, London, England
[2] ICR Inst Canc Res, Chester Beatty Labs, Breast Canc Res, London, England
[3] Royal Marsden Hosp Chelsea, Gynaecol Dept, London, England
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.04.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3P
引用
收藏
页码：S383 / S384
页数：2
相关论文
共 50 条
  • [41] Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
    Yano, Mitsutake
    Katoh, Tomomi
    Miyazawa, Mariko
    Miyazawa, Masaki
    Ogane, Naoki
    Miwa, Maiko
    Hasegawa, Kosei
    Narahara, Hisashi
    Yasuda, Masanori
    LABORATORY INVESTIGATION, 2019, 99
  • [42] Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma
    Park, Jeong Hwan
    Lee, Cheot
    Suh, Ja Hee
    Chae, Ji Yoen
    Kim, Hwal Woong
    Moon, Kyung Chul
    HUMAN PATHOLOGY, 2015, 46 (03) : 454 - 460
  • [43] Biomolecular features of ARID1A, HNF1β and ERα in clear cell carcinoma of the ovary
    Abou-Taleb, H.
    Yamaguchi, K.
    Mandai, M.
    Amano, Y.
    Kosaka, K.
    Matsumura, N.
    Baba, T.
    Yoshioka, Y.
    Hamanishi, J.
    Konishi, I
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 : 159 - 160
  • [44] Suppression of ARID1A associated with decreased CD8 T cells improves cell survival of ovarian clear cell carcinoma
    Jung, Un Suk
    Min, Kyueng-Whan
    Kim, Dong-Hoon
    Kwon, Mi Jung
    Park, HoHyun
    Jang, Hyung Seok
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 32 (01) : 1 - 13
  • [45] BAF250a (ARID1A) Expression in Ovarian Clear Cell Adenocarcinoma with an Adenofibromatous Component
    Nishikimi, K.
    Kiyokawa, T.
    Tate, S.
    Iwamoto, M.
    Kisimoto, T.
    Fugo, K.
    Shozu, M.
    MODERN PATHOLOGY, 2013, 26 : 289A - 290A
  • [46] Impact of ARID1A mutation on the tumor microenvironment of advanced clear cell ovarian cancer.
    Devlin, Michael-John
    Kristeleit, Rebecca S.
    McDermott, Jacqueline
    Maniati, Eleni
    Laforets, Florian
    Kotantaki, Panoraia
    Miller, Rowan
    Balkwill, Frances
    CANCER RESEARCH, 2021, 81 (13)
  • [47] BAF250a (ARID1A) Expression in Ovarian Clear Cell Adenocarcinoma with an Adenofibromatous Component
    Nishikimi, K.
    Kiyokawa, T.
    Tate, S.
    Iwamoto, M.
    Kisimoto, T.
    Fugo, K.
    Shozu, M.
    LABORATORY INVESTIGATION, 2013, 93 : 289A - 290A
  • [48] Mismatch repair deficiency is associated with specific morphologic features and frequent loss of ARID1A expression in ovarian clear cell carcinoma
    Ge, Huijuan
    Xiao, Yaoxin
    Qin, Guangqi
    Gu, Yanzi
    Cai, Xu
    Jiang, Wenhua
    Tu, Xiaoyu
    Yang, Wentao
    Bi, Rui
    DIAGNOSTIC PATHOLOGY, 2021, 16 (01)
  • [49] Mismatch repair deficiency is associated with specific morphologic features and frequent loss of ARID1A expression in ovarian clear cell carcinoma
    Huijuan Ge
    Yaoxin Xiao
    Guangqi Qin
    Yanzi Gu
    Xu Cai
    Wenhua Jiang
    Xiaoyu Tu
    Wentao Yang
    Rui Bi
    Diagnostic Pathology, 16
  • [50] Dual blockade of BRD4 and the ATR/WEE1 pathway exploits ARID1A loss in clear-cell ovarian cancers.
    Kinose, Yasuto
    Kim, Hyoung
    Xu, Haineng
    Medvedev, Sergey
    George, Erin
    Gitto, Sarah
    Whicker, Margaret
    Hallberg, Dorothy
    Schwartz, Lauren
    Mills, Gordon
    Velculescu, Victor E.
    Wang, Tian-Li
    Drapkin, Ronny
    Simpkins, Fiona
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 91 - 91
12345